Dr. Merlin Robb is the Deputy Director for Clinical Research for the U.S. Military HIV Research Program (MHRP). He is a board certified pediatric infectious disease specialist with research experience in molecular biology, neutralizing antibody assay development, perinatal and pediatric HIV research, HIV correlates of protection research, acute infection studies, HIV immuno-therapeutic trials, the design and conduct of Phase I, II and III clinical trials and the strategic planning and organization of vaccine development programs for East Africa. Dr. Robb was instrumental in developing MHRP’s global research infrastructure in Uganda, Kenya, Tanzania, Nigeria, Mozambique and Thailand. Dr. Robb has contributed to HIV vaccine prevention and therapy research since 1992 to include the first study to show protection from infection with an HIV vaccine, the recently completed phase III HIV vaccine trial in Thailand, also known as RV144.
Dr. Robb joined MHRP in 1990 while on active duty in the US Army and is currently employed by the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), and serves as the HJF director for MHRP. MHRP is a collaboration between HJF and the Walter Reed Army Institute of Research (WRAIR) Division of Retrovirology.